PerkinElmer’s new assay measures muscle specific creatine kinase in dried blood spots, helping to detect newborns affected by Duchenne Muscular Dystrophy.

PerkinElmer’s GSP^® Neonatal Creatine Kinase –MM kit is an immunoassay for measuring CK-MM in dried blood spot samples of newborn babies. As the assay measures the muscle specific isoform, it enables the screening process to find the babies affected by DMD. The kit is available on PerkinElmer’s GSP^® instrument, a fully automated, high throughput biochemical analyzer.

Benefits of the assay:

• The first CE-IVD kit for Duchenne Muscular Dystrophy screening
• Fully automated – no reagent preparation
• High sensitivity and specificity – good separation between affected and unaffected cases
• Wide measuring range enabling numerical result also from most of the non-affected cases
• Kit includes reagents, QC material and specific QC certificates
• Robust and reliable DELFIA^® platform performance